An Overview of Experimental and Clinical Spinal Cord Findings in Alzheimer’s Disease

An Overview of Experimental and Clinical Spinal Cord Findings in Alzheimer’s Disease

Alzheimer’s disease (AD) is a neurodegenerative disorder that occurs mainly in the elderly and presenile life stages. It is estimated that by the year 2050, 135 million people will be affected by AD worldwide, representing a huge burden to society. The pathological hallmarks of AD mainly i...

Full description

Bibliographic Details
Main Authors:	Qing Xie, Wei-Jiang Zhao, Guan-Yong Ou, Wei-Kang Xue
Format:	Article
Language:	English
Published:	MDPI AG 2019-07-01
Series:	Brain Sciences
Subjects:	Alzheimer’s disease (AD) spinal cord pathological changes β-amyloid protein tau protein inflammation
Online Access:	https://www.mdpi.com/2076-3425/9/7/168

Similar Items

The potential value of capsaicin in modulating cognitive functions in a rat model of streptozotocin-induced Alzheimer’s disease
by: Manal A. Shalaby, et al.
Published: (2019-07-01)

Chasing the effects of Pre-analytical Confounders - a Multicentre Study on CSF-AD biomarkers
by: Maria Joao Leitao, et al.
Published: (2015-07-01)

New Therapeutic Targets in Alzheimer's Disease
by: Horia Coman, et al.
Published: (2017-03-01)

Neuropathology of the Alzheimer's continuum: an update
by: Kurt A. Jellinger
Published: (2020-11-01)

Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
by: Vanessa de Jesus R. de Paula, et al.

Assessing the Possible Influence of Residues of Ractopamine, a Livestock Feed Additive, in Meat on Alzheimer Disease
by: Frank S. Fan
Published: (2021-05-01)

Alzheimer's amyloid‐β and tau protein accumulation is associated with decreased expression of the LDL receptor‐associated protein in human brain tissue
by: Claire E. Shepherd, et al.
Published: (2020-07-01)

The maze of APP processing in Alzheimer’s disease: Where did we go wrong in reasoning?
by: Ming eChen
Published: (2015-05-01)

Pathophysiology of Alzheimer’s Disease
by: Mohammad Amani
Published: (2017-01-01)

Plasmonic Nanoparticles as Optical Sensing Probes for the Detection of Alzheimer’s Disease
by: María Paz Oyarzún, et al.
Published: (2021-03-01)

Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease
by: Orestes V. Forlenza, et al.
Published: (2013-09-01)

Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
by: Nurul Husna Ibrahim, et al.
Published: (2020-03-01)

Therapeutic Effects of Natural Drugs on Alzheimer’s Disease
by: Yuan Ma, et al.
Published: (2019-12-01)

Alzheimer’s disease frequency peaks in the tenth decade and is lower afterwards
by: Jose M. Farfel, et al.
Published: (2019-07-01)

Kynurenic Acid Levels are Increased in the CSF of Alzheimer’s Disease Patients
by: Marta González-Sánchez, et al.
Published: (2020-04-01)

Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease
by: Cassia R. Overk, et al.
Published: (2009-09-01)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
by: Juanjuan Zhao, et al.
Published: (2017-07-01)

The role of autophagy in Alzheimer's disease and its potential for therapy
by: Min LIU, et al.
Published: (2014-05-01)

Physical Exercise and Alzheimer’s Disease: Effects on Pathophysiological Molecular Pathways of the Disease
by: Susana López-Ortiz, et al.
Published: (2021-03-01)

Alzheimer’s Disease—A Panorama Glimpse
by: Li Na Zhao, et al.
Published: (2014-07-01)

Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Samo Ribarič
Published: (2018-01-01)

Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis
by: Roberta Cascella, et al.
Published: (2021-05-01)

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
by: Jin Miao, et al.
Published: (2019-03-01)

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
by: Castillo-Carranza DL, et al.
Published: (2013-12-01)

Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies
by: Joana R. Guedes, et al.
Published: (2018-08-01)

Aging, Metabolism, Synaptic Activity, and Aβ in Alzheimer's Disease
by: Gunnar K. Gouras
Published: (2019-07-01)

Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease
by: Md. Sahab Uddin, et al.
Published: (2020-08-01)

In Vitro Studies of Flemish, Dutch, and Wild-Type β-Amyloid Provide Evidence for Two-Staged Neurotoxicity
by: Samir Kumar-Singh, et al.
Published: (2002-11-01)

Value of serum glucagon like peptide-1 detection in assessment of Alzheimer's disease
by: Dong-Ming Wang, et al.
Published: (2016-02-01)

Changes in Cerebrospinal Fluid Tau and β-Amyloid Levels in Diabetic and Prediabetic Patients: A Meta-Analysis
by: Yanhui Lu, et al.
Published: (2018-10-01)

The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders
by: Bruce Xue Wen Wong, et al.
Published: (2014-04-01)

THE UBIQUITIN-PROTEASOME SYSTEM: POTENTIAL THERAPEUTIC TARGETS FOR ALZHEIMER’S DISEASE AND SPINAL CORD INJURY
by: Bing eGong, et al.
Published: (2016-01-01)

Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease
by: Ming Zhao, et al.
Published: (2003-12-01)

PET Imaging of Tau Pathology: Towards an affirmative diagnosis of Alzheimer’s and Tauopathies
by: Olga eJames, et al.
Published: (2015-03-01)

Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
by: Hong-Qi Yang, et al.
Published: (2012-10-01)

Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease
by: Mandić Gorana, et al.
Published: (2008-01-01)

Modulatory Effects of Autophagy on APP Processing as a Potential Treatment Target for Alzheimer’s Disease
by: Md. Ataur Rahman, et al.
Published: (2021-12-01)

Time between milestone events in the Alzheimer's disease amyloid cascade
by: Philip S. Insel, et al.
Published: (2021-02-01)

Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
by: George Perry, et al.
Published: (2009-03-01)

Identification of a unique apolipoprotein E allele inMicrocebus murinus; apoe brain distribution and co-localization with β-amyloid and tau proteins
by: Alphonse Calenda, et al.
Published: (1995-06-01)